藥易購(300937.SZ)IPO定價12.25元/股 1月18日開啟申購
格隆匯1月15日丨藥易購(300937.SZ)披露首次公開發行股票並在創業板上市發行公吿,發行人和保薦機構(主承銷商)根據初步詢價結果,綜合考慮發行人所處行業、市場情況、同行業上市公司估值水平、募集資金需求及承銷風險等因素,協商確定此次發行價格為12.25元/股。網下發行不再進行累計投標詢價。
投資者請按此價格在2021年1月18日(T日)進行網上和網下申購,申購時無需繳付申購資金。此次網下發行申購日與網上申購日同為2021年1月18日(T日),其中,網下申購時間為9:30-15:00,網上申購時間為9:15-11:30,13:00-15:00。
根據初步詢價結果,經發行人和保薦機構(主承銷商)協商確定,此次公開發行新股2391.6671萬股,不設老股轉讓。按此次發行價格12.25元/股計算的預計募集資金總額約為2.93億元,扣除發行費用4350.59萬元(不含增值税)後,預計募集資金淨額約為2.49億元。
此次發行價格12.25元/股對應的發行人2019年扣除非經常性損益前後孰低的攤薄後市盈率為18.71倍,高於中證指數有限公司發佈的行業最近一個月平均靜態市盈率,低於同行業可比公司2019年平均靜態市盈率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.